To this end, we stimulated innate cells and T lymphocytes of COVID-19 patients at admission and before specific treatment with Toll-like receptor 7/8 (TLR 7/8) agonist and anti-CD3, respectively, and we measured the cytokines secreted. This evidence concerns the gene TLR7 and COVID-19.